OLPX: Henkel Cash Deal Will Reveal Fragile Earnings And Execution Risk

Analysts have raised the average price target for Olaplex Holdings to about $1.72 from roughly $1.41. This change reflects updated assumptions on fair value, discount rate, revenue growth, profit margin and future P/E after a mix of recent price target increases and downgrades across the Street.

Analyst Commentary

Recent research on Olaplex shows a mix of revised price targets and ratings, with some firms lifting their numbers while others turn more cautious. For you as an investor, the key message is that opinions are split on how much upside is left and how quickly the company can execute on its plans.

Several price target increases, including one to US$2 from US$1.40 at a major bank, indicate that some on the Street see room for the shares to trade closer to that level over time. At the same time, other firms have trimmed targets or moved to less favorable ratings, which feeds into the relatively modest average target of about US$1.72.

This mix of upgrades and downgrades is what sits behind the new consensus price target. It reflects different views on how reliable Olaplex's growth trajectory is, how sustainable margins might be, and what P/E multiple the stock might reasonably command if execution aligns with expectations.

Overall, the current analyst backdrop is not one sided. You are seeing both supportive and cautious signals, which makes it especially important to understand the bearish arguments that are keeping some targets and ratings in check.

Bearish Takeaways

Bearish analysts have reduced their targets from earlier levels, including a move from US$4 to US$2.50, which signals concern that prior expectations for growth and valuation were too optimistic relative to current information.
Recent downgrades highlight worries about execution risk, with some research suggesting that the company may face challenges in delivering the revenue and profit margin assumptions baked into earlier models.
Cautious research points to uncertainty around the multiple investors are willing to pay, with lower targets implying that some analysts see limited room for P/E expansion without clearer visibility on consistent growth.
The combination of fresh downgrades and reduced targets works as a cap on sentiment, reminding investors that, while there is a higher average target, there are still meaningful questions about the durability of the growth story and the timing of any improvement in fundamentals.

What's in the News

Henkel US Operations Corporation agreed to acquire Olaplex Holdings, Inc. for approximately US$1.4b in cash, valuing the shares at US$2.06 each. Olaplex is expected to retain its brand and de-list from Nasdaq once the deal closes, pending regulatory and other approvals (M&A Transaction Announcements).
Advent International, which holds more than a majority of Olaplex voting power, has already approved the Henkel transaction by written consent, so no additional shareholder vote from other investors is required. A US$40.44 million termination fee applies if the deal is not completed (M&A Transaction Announcements).
Olaplex issued 2026 earnings guidance, with net sales expected in a range of US$414 million to US$435 million. Management indicated that net sales for the first quarter are expected to be lower than the full year run rate, with demand weighted towards the second half of the year (Corporate Guidance).
Olaplex launched No.3PLUS Complete Repair Treatment, a new pre shampoo product that uses the company’s Bond Building Technology and Damage Defense Cationic Complex. The launch is supported by a “Science Never Looked So Good” marketing campaign featuring actor and comedian Chloe Fineman as Chief Hair Officer (Product Related Announcements).
The new No.3PLUS product is available across multiple channels, including OLAPLEX.com, Sephora, Ulta, SalonCentric, Beauty Systems Group, TikTok Shop and Amazon, expanding access across both professional and retail distribution partners (Product Related Announcements).

Valuation Changes

Fair Value: Raised modestly from about $1.41 to roughly $1.72 per share, indicating a slightly higher assessed value for the stock.
Discount Rate: Edged up from about 7.42% to roughly 7.74%, a small change that can slightly reduce the present value of future cash flows in valuation models.
Revenue Growth: Assumed growth rate moved from about 1.50x to roughly 1.55x, a small upward shift in expectations for future revenue expansion used in the model.
Net Profit Margin: Adjusted from around 5.41% to approximately 5.73%, reflecting a modestly higher margin assumption on future earnings.
Future P/E: Multiple increased from about 49.7x to roughly 57.7x, implying a higher valuation multiple being applied to projected earnings in the updated framework.

1 view

Key Takeaways

Olaplex's premium, science-backed brand and digital growth are challenged by shifting consumer habits, intensifying competition, and risks of market saturation and product fatigue.
Heavy reliance on discretionary spending, variable international execution, and exposure to economic pressures create uncertainty for sustainable revenue and margin expansion.
Declining sales, shifting consumer habits, reduced retail presence, and costly transformation efforts threaten revenue growth, market position, and margin recovery prospects.

Catalysts

About Olaplex Holdings

Through its subsidiaries, develops, manufactures, and sells haircare products in the United States and internationally.What are the underlying business or industry changes driving this perspective?

Although global consumer interest in health, wellness, and self-care continues to support demand for science-backed, premium haircare products-giving Olaplex opportunities to leverage its patented bond-building technology-the company faces persistent weakness in specialty retail, with year-to-date net sales down and retail channel growth pressured by evolving consumer habits toward minimalist beauty and lower frequency salon visits, which may weigh on future revenue growth.
While innovation remains a central pillar for Olaplex, demonstrated by three new product launches this year and movement into fast-growing niches like scalp health, these benefits are countered by the risk of product fatigue and the challenge of sustaining rapid innovation against rising competition from both established personal care players and agile indie brands, putting long-term gross margins and market share at risk.
Direct-to-consumer and digital strategies have driven double-digit growth in that channel and enabled higher-margin sales, yet greater proliferation of private label and influencer-driven competitors online continues to intensify, potentially raising customer acquisition costs and compressing net margins even as Olaplex invests heavily in marketing and technology.
Despite successful execution of a refreshed brand identity and investments in a full-funnel digital content engine that have led to improved leading indicators (such as increased social mentions and brand engagement), Olaplex's heavy reliance on premium positioning leaves it exposed to ongoing discretionary income pressures from economic polarization, limiting the total addressable market and causing potential stagnation in top-line growth.
Although international expansion and a tiered go-to-market strategy could drive diversification and incremental revenues over the long term, ongoing efforts to rationalize distributor partnerships and variable execution across markets mean that the timing and profitability of these initiatives remain uncertain, prolonging volatility in earnings and delaying consistent improvement in global net sales.

Olaplex Holdings Earnings and Revenue Growth

Olaplex Holdings Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

This narrative explores a more pessimistic perspective on Olaplex Holdings compared to the consensus, based on a Fair Value that aligns with the bearish cohort of analysts.
The bearish analysts are assuming Olaplex Holdings's revenue will grow by 1.5% annually over the next 3 years.
The bearish analysts assume that profit margins will increase from -2.2% today to 5.7% in 3 years time.
The bearish analysts expect earnings to reach $25.4 million (and earnings per share of $0.03) by about May 2029, up from -$9.3 million today. However, there is some disagreement amongst the analysts with the more bullish ones expecting earnings as high as $139.4 million.
In order for the above numbers to justify the price target of the more bearish analyst cohort, the company would need to trade at a PE ratio of 57.8x on those 2029 earnings, up from -147.4x today. This future PE is greater than the current PE for the US Personal Products industry at 22.4x.
The bearish analysts expect the number of shares outstanding to grow by 0.52% per year for the next 3 years.
To value all of this in today's terms, we will use a discount rate of 7.74%, as per the Simply Wall St company report.

Risks

What could happen that would invalidate this narrative?

Flat net sales year-to-date and modest guidance of minus 3 percent to plus 2 percent sales growth for fiscal 2025, following consecutive prior years of sales declines, indicate ongoing consumer and channel weakness that may pressure revenue growth over the long term.
Declines in the specialty retail channel and shifts toward more strategic but fewer promotional events could further erode retail sales volumes, reducing the company's total revenue and market presence in the crucial prestige distribution landscape.
Ongoing transformation initiatives across international markets, including distributor rationalization and a tiered go-to-market approach, introduce significant execution risk that could delay or derail top-line recovery and expansion, especially as international sales are currently down.
Increasing investments in sales, marketing, and people have driven a material reduction in adjusted EBITDA margins from over 33 percent to approximately 24.7 percent year-to-date, with further pressure expected as transformation continues, thereby impacting net margins and longer-term earnings.
Changing consumer habits in the professional salon channel, such as reduced salon visit frequency and the trend towards lower maintenance and more natural hair color, directly reduce the demand for Olaplex's core offerings, threatening both recurring revenue streams and category growth prospects.

Valuation

How have all the factors above been brought together to estimate a fair value?

The assumed bearish price target for Olaplex Holdings is $1.72, which represents up to two standard deviations below the consensus price target of $1.98. This valuation is based on what can be assumed as the expectations of Olaplex Holdings's future earnings growth, profit margins and other risk factors from analysts on the more bearish end of the spectrum.
However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $2.06, and the most bearish reporting a price target of just $1.65.
In order for you to agree with the more bearish analyst cohort, you'd need to believe that by 2029, revenues will be $442.9 million, earnings will come to $25.4 million, and it would be trading on a PE ratio of 57.8x, assuming you use a discount rate of 7.7%.
Given the current share price of $2.03, the analyst price target of $1.72 is 17.7% lower. Despite analysts expecting the underlying business to improve, they seem to believe the market's expectations are too high.
We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on Olaplex Holdings?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Disclaimer

AnalystLowTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystLowTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystLowTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Declining Specialty Retail Will Challenge Turnaround Though Some Upside Persists